Home
About Us
NIHR Imperial BRC Team
Equality, Diversity and Inclusion (EDI) Strategy
NIHR Infrastructures
Acknowledgement
NIHR Imperial BRC Branding Guidance
Research
Biomedical Engineering
Brain Sciences
Cardiovascular
Digestive Diseases
Digital Health
Immunology
Infection & Antimicrobial Resistance
Metabolic & Endocrinology
Molecular Phenotyping
Multiple Long-Term Conditions
Pregnancy & Prematurity
Respiratory
Social Genetic & Environmental Determinants of Health
Surgery & Cancer
Facilities/Services
Clinical Imaging Facility
Clinical Phenotyping Centre
Flow Cytometry
Genomics Facility
Imperial College Healthcare Tissue Bank
Imperial Clinical Analytics, Research and Evaluation (iCARE)
Imperial Clinical Trials Unit
Imperial Health Knowledge Bank (IHKB)
Organoid Facility
Patient Experience Research Centre (PERC)
The Leonard and Dora Colebrook Laboratory
Patient/Public
Research We Are Supporting
How You Can Get Involved
Information for Researchers
Public Involvement, Engagement and Participation in Research Summary Strategy
Industry/Partners
Collaborations
Contract
Commercialisation
Training
Non-Medical Opportunities
Chain-Florey Fellowships & Lecturers
Clinical Academic Training Office
Other Training Schemes
News & Events
Upcoming Events
Newsletter
Contact Us
First in Human Stories
First in Human
Innovation
Partnership
First patient-derived in vitro model to study proteostasis deregulation in disease
Published on
28
th
September 2018
First in Human
Innovation
Partnership
Therapeutic
NIHR infrastructure at Imperial: the Clinical Research Facility
Published on
20
th
September 2018
First in Human
Innovation
Potent psychedelic DMT mimics near-death experience in the brain
Published on
24
th
August 2018
First in Human
Therapeutic
Allergic responses linked to skin cancer protection
Published on
23
rd
July 2018
First in Human
Innovation
Partnership
Therapeutic
Imperial-developed cancer drug enters phase I clinical trial
Published on
12
th
January 2018
Next page »
« Previous page